Bioresorbable scaffold implantation in patients with indication for oral anticoagulation: A propensity matched analysis

There was no difference in bleeding or ischemic events between the patients on TAT and those on DAPT after BRS implantation. The high rate of scaffold thrombosis in all of these patients, however, is not negligible.